Evidence map›Paper›PMID 30842323›Full record

ArticleJournal of virology2019

Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract.

Batsirai M Mabvakure, Bronwen E Lambson, Kavisha Ramdayal, Lindi Masson, Dale Kitchin, Mushal Allam, Salim Abdool Karim, Carolyn Williamson, Jo-Ann Passmore, Darren P Martin and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Batsirai M Mabvakure *Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-2760-5443
Bronwen E Lambson *Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Kavisha RamdayalSouth African MRC Bioinformatics Capacity Development Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.
Lindi MassonInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Dale KitchinCentre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Mushal AllamSequencing Core Facility, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-9875-6716
Salim Abdool KarimCentre for the AIDS Programme of Research in South Africa (CAPRISA), KwaZulu-Natal, South Africa.
Carolyn WilliamsonInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Jo-Ann PassmoreInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Darren P MartinInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Cathrine ScheepersCentre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Penny L MooreCentre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-8719-4028
Gordon W HarkinsSouth African MRC Bioinformatics Capacity Development Unit, South African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.
Lynn MorrisCentre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa lynnm@nicd.ac.za.ORCID 0000-0003-3961-7828
National Health Laboratory Service · ZAUniversity of Cape Town · ZAUniversity of the Western Cape · ZACentre for the AIDS Programme of Research in South Africa · ZA

Funding

The Viral Set Point in HIV-1 Subtype C InfectionU19AI051794 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2002 to 2007
$22.5M
NIAID NIH HHS U19 AI051794
6 · The paper itself

Abstract

HIV-1 has been shown to evolve independently in different anatomical compartments, but studies in the female genital tract have been inconclusive. Here, we examined evidence of compartmentalization using HIV-1 subtype C envelope (Env) glycoprotein genes (gp160) obtained from matched cervicovaginal lavage (CVL) and plasma samples over 2 to 3 years of infection. HIV-1 gp160 amplification from CVL was achieved for only 4 of 18 acutely infected women, and this was associated with the presence of proinflammatory cytokines and/or measurable viremia in the CVL. Maximum likelihood trees and divergence analyses showed that all four individuals had monophyletic compartment-specific clusters of CVL- and/or plasma-derived gp160 sequences at all or some time points. However, two participants (CAP177 and CAP217) had CVL gp160 diversity patterns that differed from those in plasma and showed restricted viral flow from the CVL. Statistical tests of compartmentalization revealed evidence of persistent compartment-specific gp160 evolution in CAP177, while in CAP217 this was intermittent. Lastly, we identified several Env sites that distinguished viruses in these two compartments; for CAP177, amino acid differences arose largely through positive selection, while insertions/deletions were more common in CAP217. In both cases these differences contributed to substantial charge changes spread across the Env. Our data indicate that, in some women, HIV-1 populations within the genital tract can have Env genetic features that differ from those of viruses in plasma, which could impact the sensitivity of viruses in the genital tract to vaginal microbicides and vaccine-elicited antibodies.

Indexed as

AdolescentAdultenv Gene Products, Human Immunodeficiency VirusFemaleGenitalia, FemaleHIV-1HIV AntibodiesHIV Envelope Protein gp160HIV InfectionsHIV SeropositivityHumansLongitudinal StudiesMiddle AgedOrgan SpecificityPhylogenyReproductive Tract Infectionsenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesHIV Envelope Protein gp160RNA, Viralcompartmentalizationcytokinesevolutiongenital tract immunityhuman immunodeficiency virusphylogenetic analysis

Identifiers

PMID30842323
PMCPMC6498054
OpenAlexW2921747626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.